Table 1.
T0 | Tadalafil 1 μM | |||
---|---|---|---|---|
T2 | T6 | T24 | ||
tGSHa | 130.38 ± 1.88 | 146.56 ± 3.03# | 158.78 ± 10.07# | 149.41 ± 12.13 |
GSSGa | 14.23 ± 1.26 | 17.09 ± 0.93* | 21.18 ± 1.19# | 17.10 ± 2.85 |
GSHa | 116.14 ± 2.08 | 129.46 ± 2.13* | 137.61 ± 10.08* | 132.31 ± 9.60* |
TACb | 0.38 ± 0.07 | 0.39 ± 0.06 | 0.40 ± 0.02 | 0.41 ± 0.06 |
Measurement of total (tGSH), oxidized (GSSG), and reduced glutathione (GSH) and total antioxidant capacity (TAC) was performed in C2C12 myotubes after 2, 6, or 24 h (T0-T24) of tadalafil (1 μM) treatments. Data presented are the mean ± SD of three experiments
*p < 0.05 vs T0; #p < 0.01 vs T0
anmol/mg protein
bμmol Trolox/mg protein